BRIEF-EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Side Effect

Jan 20 (Reuters) - European Medicines Agency:

* EMA: ASSESSMENT OF WHETHER VACCINATION CAN CAUSE CAPILLARY LEAK SYNDROME (IS ONGOING FOR PFIZER AND MODERNA COVID-19 VACCINES

* EMA SAYS FOR SPIKEVAX, PRODUCT INFORMATION WILL BE UPDATED TO INCLUDE PARAESTHESIA (UNUSUAL FEELING IN THE SKIN) AS A RARE SIDE EFFECT

* EMA: IN JANUARY 2022, PRAC CONCLUDED THAT TRANSVERSE MYELITIS SHOULD BE ADDED TO THE PRODUCT INFORMATION AS A SIDE EFFECT OF ASTRAZENECA VACCINE Further company coverage:

Our Standards: The Thomson Reuters Trust Principles.